Overview

* Biorem ( BIRMF ) Q3 revenue down 24% yr/yr to C$11.3 mln

* EPS for Q3 falls to C$0.07 from C$0.14 last year

* Company reports record order backlog of C$71 mln

Outlook

* Biorem ( BIRMF ) expects strong revenue and earnings growth over the next 12 months

* Company reports record order backlog of C$71 mln as of September 30, 2025

* Biorem ( BIRMF ) anticipates continued growth in order bookings

Result Drivers

* ORDER BACKLOG - Record order backlog of C$71 mln driven by strong order bookings and strategic product adjustments

* REVENUE IMPACT - Revenue decline attributed to customer construction timelines and delivery schedules

* OPERATING EXPENSES - Decrease in operating expenses due to lower sales and marketing costs

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 C$11.25

Revenue mln

Q3 EPS C$0.06

Q3 Net C$1.16

Income mln

Q3 Basic C$0.07

EPS

Q3 Gross C$3.17

Profit mln

Q3 C$1.55

Operatin mln

g

Expenses

Analyst Coverage

* The one available analyst rating on the shares is "buy"

* The average consensus recommendation for the environmental services & equipment peer group is "buy"

* Wall Street's median 12-month price target for Biorem Inc ( BIRMF ) is C$3.50, about 38.6% above its November 14 closing price of C$2.15

* The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)